JAMA Report Videos

The following are JAMA Report videos made publicly available once the related article in JAMA has published.

  • June 13, 2017

    Video of drone delivering an AED

  • June 10, 2017

    Glucose Self-Monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes

    Glucose Self-Monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes

    TRT:

     

    INTRO: Many people with type 2 diabetes not treated with insulin self-monitor their blood sugar levels. But the value of this practice has been debated. So how effective is self-monitoring for these patients when it comes to glycemic control and health-related quality of life? A new study in JAMA Internal Medicine investigates. Laura Berger has more in this week’s JAMA report.

     

    AUDIO:

    VO:

     

    MANY PATIENTS WITH TYPE 2 DIABETES NOT TREATED WITH INSULIN SELF MONITOR THEIR BLOOD SUGAR LEVELS AT HOME … PATIENTS LIKE APRIL REESE.

     

    (B-ROLL: Doctor and patient April talking and looking at paper of levels)

     

    AUDIO:

    SOT/FULL

    April Reese, Living with Type 2 Diabetes

    Super@: 7

    Runs: 9

     

    “A couple of times a week I am testing to make sure that I’m in the right range or if I feel like something’s wrong I test.”

     

    AUDIO:

    VO:

    BUT HOW EFFECTIVE IS SELF- MONITORING FOR PATIENTS LIKE APRIL? DR. KATRINA DONAHUE AND DR. LAURA YOUNG OF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL AND THEIR COLLEAGUES STUDIED 450 ADULTS WHO HAD NON-INSULIN-TREATED TYPE 2 DIABETES.

     

    RESEARCHERS WANTED TO KNOW IF SELF-MONITORING BLOOD GLUCOSE LEVELS AFFECTED DIABETES CONTROL BY LOOKING AT PATIENTS’ HEMOGLOBIN A1C LEVELS, A MEASURE OF LONGER-TERM SUGAR CONTROL, OR THEIR HEALTH-RELATED QUALITY OF LIFE.

    IN THE RANDOMIZED TRIAL, PATIENTS

    WERE DIVIDED INTO THREE GROUPS, ONE GROUP DID NOT DO SELF-MONITORING, THE SECOND GROUP DID ONCE DAILY SELF-MONITORING, AND THE THIRD GROUP MONITORED ONCE DAILY TOO BUT ALSO RECEIVED MESSAGES WITH ENCOURAGEMENT OR INSTRUCTION THROUGH THEIR METER.

     

    THE STUDY APPEARS IN JAMA INTERNAL MEDICINE.

     

    (B-ROLL: Dr. and April talking, Drs. Walking down the hall, Drs. at computer, April preparing to test her blood, looking at levels, checking foot, April testing blood, looking at monitor with Doctor)

     

     

    AUDIO:

    SOT/FULL

    Katrina Donahue MD, MPH, University of North Carolina at Chapel Hill

    Super@: 1:02

    Runs: 13

     

    SOT/FULL

    Laura Young MD, PhD, University of North Carolina at Chapel Hill

    Super@: 1:16

    Runs: 20

     

    “After one year, we found no significant differences in A1C or glycemic control between the three groups. Also there were no significant differences in health-related quality of life.”

     

     “The next steps are getting the message out and really helping patients understand as well as health care providers the message from this study…and helping patients feel comfortable recognizing that testing may not be necessary especially for those who are used to doing it once or multiple times a day.”

     

    (b-roll in middle of 2nd bite of patient)

     

    VO:

    STUDY RESULTS DO NOT APPLY TO INSULIN-TREATED PATIENTS.   

     

    APRIL REESE SAYS THE RESULTS ARE WORTH A CONVERSATION WITH HER DOCTOR ABOUT THE VALUE OF SELF-MONITORING.

     

    (B ROLL: Doctor and patient talking)

     

    AUDIO:

    SOT/FULL

    April Reese, Living with Type 2 Diabetes

    Super@: 1:44

    Runs:11

     

    “I will talk with my doctor about these results so that we can look at my treatment plan and make some decisions moving forward about how I want to be managed.”

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: Dr. talking to patient)

     

    TAG: THE STUDY WAS PERFORMED AT 15 PRIMARY CARE PRACTICES IN NORTH CAROLINA.

     

     

  • June 01, 2017

    Smartphone Video of Acute Onset of Uncontrolled Eye Movement

    Smartphone Video of Acute Onset of Uncontrolled Eye Movement

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

    JAMA Otolaryngology-Head & Neck Surgery

    Embed this video: Copy and paste the link below to embed the video on your website.

  • June 01, 2017

    After Treatment for Acute Onset of Uncontrolled Eye Movement

    After Treatment for Acute Onset of Uncontrolled Eye Movement

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

    JAMA Otolaryngology-Head & Neck Surgery

    Embed this video: Copy and paste the link below to embed the video on your website.

  • June 01, 2017

    Video Accompanies JAMA Facial Plastic Surgery Surgical Pearls Article

    Video Accompanies JAMA Facial Plastic Surgery Surgical Pearls Article

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

     

    JAMA Facial Plastic Surgery

    A video accompanies the Surgical Pears article, “The Columella Retraction Suture: A Powerful Suture Technique,” published by JAMA Facial Plastic Surgery.

    For more details and to view the video and get the embed code, please visit the For The Media website.

    (doi:10.1001/jamafacial.2017.0215)

    Editor’s Note:  Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

    #  #  #

    Embed this video: Copy and paste the link below to embed the video on your website.

  • May 16, 2017

    Corticosteroid Injections for Knee Osteoarthritis

    Corticosteroid Injections for Knee Osteoarthritis

    INTRO: Knee osteoarthritis affects millions of people in the United States and there are no known treatments that stop progression of the condition. A new study in JAMA investigates whether corticosteroid injections could slow the progression of cartilage loss and alleviate the pain of knee osteoarthritis. Laura Berger has more in this week’s JAMA report.

    AUDIO:

    VO:

    KNEE OSTEOARTHRITIS IS A LEADING CAUSE OF DISABILITY AND A DRIVER OF RISING MEDICAL COSTS BECAUSE THE PAINFUL CONDITION CAN OFTEN LEAD TO KNEE REPLACEMENT SURGERY.

    (B-ROLL: doctor checking patient’s knees)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 10

    Runs: 22

    “It’s expensive because of out of pocket costs for medical treatments, work loss, and also being the main reason for needing a joint replacement. Furthermore, there is currently no treatment accepted to benefit osteoarthritis in the long term and especially to reduce its rate of progression.”

    AUDIO:

    VO:

    1. TIMOTHY MCALINDON OF TUFTS MEDICAL CENTER IN BOSTON AND HIS COLLEAGUES STUDIED 140 ADULTS WITH KNEE OSTEOARTHRITIS IN A RANDOMIZED CLINICAL TRIAL.

    HALF OF THE PATIENTS RECEIVED A KNEE INJECTION OF THE CORTICOSTEROID TRIAMCINOLONE EVERY THREE MONTHS FOR TWO YEARS, WHILE THE OTHER HALF GOT SALT WATER INJECTIONS.

    THE RESEARCHERS MEASURED THE LEVEL OF KNEE PAIN AT EACH VISIT AND PERFORMED MRI SCANS ANNUALLY TO MEASURE CHANGES IN CARTILAGE AND OTHER STRUCTURES WITHIN THE JOINT.

    THE STUDY APPEARS IN JAMA, THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

    (B-ROLL: Dr. examining patient, knee exercises, steroid close up, knee exam, various MRI scans)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 1:04

    Runs: 39 seconds

    (broll comes in at 1:11—1:37 of doctor examining patient, MRI scans, and the steroid)

    “Both groups experienced some improvement in pain but there was no difference between the groups at any time point. Physical function remained about the same, and when we looked at the MRI scans, while there were no major differences between the groups, the precise measures of cartilage and volume showed more loss in the group that had been assigned to the corticosteroid. // The results of the studies do not support the use of long term repeated corticosteroid injections for the management of pain, or structural progression in osteoarthritis and in fact indicate that there may be more cartilage loss in people who receive steroids.”

    VO: DR. MCALINDON SAYS MORE WORK NEEDS TO BE DONE TO FIND A LONG-TERM SOLUTION FOR PEOPLE WITH KNEE OSTEOARTHRTIS.

    (B ROLL: Doctor and patient knee exam)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 1:49

    Runs:15

    “Osteoarthritis is a very common disorder for which there is currently no effective long-term treatment so we need to find interventions to reduce the incidence and progression of this disabling disorder.”

    VO:

    LAURA BERGER, THE JAMA REPORT

    (BROLL: Dr. talking to patient)

    THE STUDY WAS PERFORMED AT TUFTS MEDICAL CENTER FROM 2011 to 2015.

  • April 18, 2017

    Study Examines Effectiveness of Steroid Medication for Sore Throat

    Study Examines Effectiveness of Steroid Medication for Sore Throat

    Study Examines Effectiveness of Steroid Medication for Sore Throat”

    TRT: 1:47

    INTRO: SORE THROAT IS A COMMON SYMPTOM THAT SENDS PATIENTS TO THEIR DOCTORS, WHO OFTEN PRESCRIBE ANTIBIOTICS WHEN THEY WON’T HELP AND AREN’T NEEDED. FINDING ALTERNATIVE STRATEGIES TO RELIEVE SORE THROAT SYMPTOMS AND REDUCE ANTIBIOTIC USE IS IMPORTANT. A NEW STUDY IN JAMA INVESTIGATES WHETHER A CORTICOSTEROID PILL RESOLVES SORE THROAT SYMPTOMS IN ADULTS WHO DON’T REQUIRE ANTIBIOTICS. LAURA BERGER HAS MORE IN THIS WEEK’S JAMA REPORT.

    AUDIO:

    VO:

     PATIENTS IN THE U.S. MADE 92 MILLION VISITS TO DOCTORS FOR SORE THROATS BETWEEN 1997 AND 2010. MANY OF THOSE PATIENTS RECEIVED UNNECESSARY ANTIBIOTICS.

    (B-ROLL: doctor checking patient’s throat)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 11

    Runs: 14

    “We know the more antibiotics that we take, the more likely we are to develop infections which are resistant to antibiotics in the future. So it’s important to try and find alternative treatments…we wanted to know if steroids could be an alternative treatment for sore throat.”

    AUDIO:

    VO:

    1. GAIL HAYWARD OF THE UNIVERSITY OF OXFORD AND HER COLLEAGUES STUDIED ALMOST 600 ADULTS WITH SORE THROATS WHO DIDN’T REQUIRE IMMEDIATE ANTIBIOTICS FROM CLINICS IN ENGLAND AS PART OF A RANDOMIZED TRIAL. HALF THE PATIENTS TOOK A 10-MILLIGRAM DOSE OF THE CORTICOSTEROID DEXAMETHASONE WHILE THE OTHER HALF RECEIVED A PLACEBO.

    THE RESEARCHERS THEN MEASURED WHETHER SORE THROAT SYMPTOMS WERE COMPLETELY RESOLVED AFTER ONE OR TWO DAYS.

    THE STUDY APPEARS IN JAMA, THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

    (B-ROLL: Dr. Hayward walking down hallway, working on computer, patient getting throat exam, shot of dexamethasone, patient exam)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 53

    Runs: 17

    “After 24 hours, we didn’t see any difference in the proportion of patients who felt better between those taking the steroid and those taking the placebo. However, at 48 hours we did see a difference, more patients in the group that took the steroid tablet felt completely better, than patients in the placebo group.”

    VO: ALTHOUGH MORE PATIENTS WHO TOOK THE STEROID FELT COMPLETELY BETTER AFTER 48 HOURS, DR. HAYWARD SAYS THERE ARE MANY DOWNSIDES TO TAKING STEROIDS, INCLUDING DIFFICULTY SLEEPING, ACID REFLUX, AND INCREASED APPETITE.

    (B ROLL: Doctor checking patient’s ears, talking to patient, shot of drug)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 1:23

    Runs: 23

    “We think that although steroids are probably not ideal to be used in primary care for all patients presenting with sore throat, what our study couldn’t really do is look at those patients with very severe sore throat. We think that its possible that in very severe sore throat steroids might help patients be able to swallow fluids and medication, and avoid needing to go to hospital which could be very beneficial, but this research has not yet been done.​”

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: Doctor using tongue depressor on patient)

    TAG: THE STUDY STARTED IN 2013 AND ENDED IN 2015.

  • March 28, 2017

    Screening for Celiac Disease: USPSTF Recommendation Statement

    Screening for Celiac Disease: USPSTF Recommendation Statement

    Celiac disease is intolerance to gluten, a protein complex found in wheat and some other grains.  When people with celiac disease eat foods with gluten their immune response damages the lining of the small intestine, causing gastrointestinal and other symptoms.

    The selection of gluten-free foods in the grocery store is proof enough that many people worry they might have celiac disease, but should doctors be screening people for it?

    Remember, screening means looking for disease in people without symptoms or signs of it;

    Screening for celiac disease typically involves drawing blood for serum antibody levels and following up with an intestinal biopsy.

    The United States Preventive Services Task Force, an independent volunteer panel of national experts in prevention and evidence-based medicine, has now reviewed the literature and concludes that we don’t have enough information to know.

    Some groups still recommend screening higher risk patients for celiac disease, but the Task Force says there are simply no good studies demonstrating the accuracy of testing in asymptomatic populations, or the benefits and harms of early detection and treatment of screen-detected disease.

    So if your patients’ main symptom is anxiety about gluten sensitivity or celiac disease, you’re probably OK holding off on testing, unless other symptoms raise suspicions for the disorder. And if you do screen, patients should understand that the balance of benefit and harm is uncertain.

    Thanks for listening, hope to see you soon and don’t forget to click the link in the description to read the entire recommendation statement.

  • February 21, 2017

    The Effects of Testosterone Gel on Health Outcomes

    The Effects of Testosterone Gel on Health Outcomes

    INTRO: Can testosterone gel improve memory, correct anemia, increase bone density or prevent the growth of coronary artery plaque in older men with low testosterone levels? Four new studies in JAMA and JAMA Internal Medicine found improvement in some of these measures.  Laura Berger has more in this week’s JAMA Report.

     

    AUDIO:

    VO:

     

    LOW TESTOSTERONE LEVELS ARE COMMON IN OLDER MEN. FOUR NEW STUDIES IN JAMA AND JAMA INTERNAL MEDICINE LOOKED AT WHETHER USING A TESTOSTERONE GEL COULD AFFECT CERTAIN HEALTH OUTCOMES.

     

    (B-ROLL:

    Men working out on a track, and stretching, Close-up of testosterone gel, walking on track)

     

     

    AUDIO:

    SOT/FULL

    Peter Snyder, MD, Professor of Medicine, University of Pennsylvania

    Super@: 12

    Runs: 19

     

    “We selected men over 65 who had low testosterone levels. We treated them with either testosterone or placebo for one year.  We studied their blood counts, their bone density, the amount of plaque in their coronary arteries, and their memory.”

     

     

     

    AUDIO:

    VO:

     

    THE WORK BY DR. PETER SNYDER OF THE UNIVERSITY OF PENNSYLVANIA AND HIS CO-AUTHORS WAS PART OF A GROUP OF COORDINATED TRIALS ON THE EFFECTS OF TESTOSTERONE GEL IN OLDER MEN WITH LOW TESTOSTERONE LEVELS.

     

    RESEARCHERS FOUND THE TESTOSTERONE GEL CORRECTED ANEMIA AND INCREASED BONE DENSITY MORE THAN PLACEBO, BUT IT DID NOT IMPROVE MEMORY AND IT INCREASED THE AMOUNT OF CORONARY ARTERY PLAQUE.

     

    1. SNYDER SAYS THAT THE INCREASE IN THE AMOUNT OF CORONARY ARTERY PLAQUE COULD BE AN EARLY SIGN OF INCREASED RISK OF HEART PROBLEMS. AND THE STUDIES DID NOT LOOK AT PROSTATE CANCER, WHICH CAN GROW IN RESPONSE TO TESTOSTERONE.

     

    (B-ROLL: Dr. Snyder walking down the hall, on the phone, working on computer, Testosterone gel bottle, doctor with gel and patient, men stretching at gym, man on computer, picture of artery, bottle of testosterone gel)

     

    AUDIO

    SOT/FULL

    Peter Snyder, MD, Professor of Medicine, University of Pennsylvania

    Super@ 1:04

    Runs: 17

     

    “The next step is to conduct a much larger and longer trial say of 5,000 men for 5 years to determine if testosterone increases the risk of heart attack or increases the risk of prostate cancer. Or if it reduces the risk of bone fracture.”

     

     

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: men walking on a track)

     

    TAG: THE TESTOSTERONE TRIALS WERE CONDUCTED FROM 2010 TO 2014.

  • January 30, 2017

    Mentally Stimulating Activities in Late Life and Risk of Mild Cognitive Impairment

    Mentally Stimulating Activities in Late Life and Risk of Mild Cognitive Impairment

    INTRO: Can brain-stimulating activities help older adults lower their risk of developing mild cognitive impairment? A new study in JAMA Neurology suggests certain activities may be associated with less risk. Laura Berger has more in this week’s JAMA Report.

     

    AUDIO:

    VO:

    MILD COGNITIVE IMPAIRMENT OR MCI IS THE INTERMEDIATE STAGE BETWEEN NORMAL AGING AND DEMENTIA.

     

     

    (B-roll: woman working at a computer)

     

     

    SOT/FULL

    Yonas Geda, MD, MSc, Professor of Neurology and Psychiatry, Mayo Clinic

    Super@:8

    Runs:16

     

    “The frequency of MCI, depends on age. If you take a person 70 year and older, for example in our study, we have observed that the frequency or prevalence of MCI is about 15%.”

     

    AUDIO:

    VO:

     

    1. YONAS GEDA (GAY-da) OF THE MAYO CLINIC IN SCOTTSDALE, ARIZONA AND CO-AUTHORS STUDIED ALMOST 2 THOUSAND COGNITIVELY NORMAL ADULTS 70 AND OLDER TO SEE IF ENGAGING IN MENTALLY STIMULATING ACTVITIES WAS ASSOCIATED WITH DECREASED RISK FOR DEVELOPING MCI.

     

    THE OLDER ADULTS WERE FROM A MAYO CLINIC STUDY OF AGING IN MINNESOTA. THEY COMPLETED QUESTIONNAIRES ABOUT THEIR ACTIVITIES AND UNDERWENT ASSESSMENTS, INCLUDING FOR MEMORY. 

     

    RESEARCHERS FOUND PLAYING GAMES, CRAFTING, USING A COMPUTER AND SOCIAL ACTIVITIES WERE ASSOCIATED WITH DECREASED RISK OF MCI.

     

     

     

    (B-ROLL:

    Dr. walking with a woman, looking at data, man on I-pad, woman doing a puzzle, man on I-pad, woman with doctor)

     

    AUDIO:

    Yonas Geda, MD, MSc, Professor of Neurology and Psychiatry, Mayo Clinic

    Super@:49

    Runs:15

    SOT/FULL

     

    “This study is very important because dementia, MCI, these conditions are really common as we get older. We need to find out non-pharmacological approach to decrease the risk of MCI or dementia.”

     

    LAURA BERGER, THE JAMA REPORT

    (BROLL: woman doing a puzzle)

     

         TAG:THE STUDY LOOKED AT DATA FROM APRIL 2006 TO JUNE 2016.

     

  • June 13, 2017

    Video of drone delivering an AED

  • June 10, 2017

    Glucose Self-Monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes

    Glucose Self-Monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes

    TRT:

     

    INTRO: Many people with type 2 diabetes not treated with insulin self-monitor their blood sugar levels. But the value of this practice has been debated. So how effective is self-monitoring for these patients when it comes to glycemic control and health-related quality of life? A new study in JAMA Internal Medicine investigates. Laura Berger has more in this week’s JAMA report.

     

    AUDIO:

    VO:

     

    MANY PATIENTS WITH TYPE 2 DIABETES NOT TREATED WITH INSULIN SELF MONITOR THEIR BLOOD SUGAR LEVELS AT HOME … PATIENTS LIKE APRIL REESE.

     

    (B-ROLL: Doctor and patient April talking and looking at paper of levels)

     

    AUDIO:

    SOT/FULL

    April Reese, Living with Type 2 Diabetes

    Super@: 7

    Runs: 9

     

    “A couple of times a week I am testing to make sure that I’m in the right range or if I feel like something’s wrong I test.”

     

    AUDIO:

    VO:

    BUT HOW EFFECTIVE IS SELF- MONITORING FOR PATIENTS LIKE APRIL? DR. KATRINA DONAHUE AND DR. LAURA YOUNG OF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL AND THEIR COLLEAGUES STUDIED 450 ADULTS WHO HAD NON-INSULIN-TREATED TYPE 2 DIABETES.

     

    RESEARCHERS WANTED TO KNOW IF SELF-MONITORING BLOOD GLUCOSE LEVELS AFFECTED DIABETES CONTROL BY LOOKING AT PATIENTS’ HEMOGLOBIN A1C LEVELS, A MEASURE OF LONGER-TERM SUGAR CONTROL, OR THEIR HEALTH-RELATED QUALITY OF LIFE.

    IN THE RANDOMIZED TRIAL, PATIENTS

    WERE DIVIDED INTO THREE GROUPS, ONE GROUP DID NOT DO SELF-MONITORING, THE SECOND GROUP DID ONCE DAILY SELF-MONITORING, AND THE THIRD GROUP MONITORED ONCE DAILY TOO BUT ALSO RECEIVED MESSAGES WITH ENCOURAGEMENT OR INSTRUCTION THROUGH THEIR METER.

     

    THE STUDY APPEARS IN JAMA INTERNAL MEDICINE.

     

    (B-ROLL: Dr. and April talking, Drs. Walking down the hall, Drs. at computer, April preparing to test her blood, looking at levels, checking foot, April testing blood, looking at monitor with Doctor)

     

     

    AUDIO:

    SOT/FULL

    Katrina Donahue MD, MPH, University of North Carolina at Chapel Hill

    Super@: 1:02

    Runs: 13

     

    SOT/FULL

    Laura Young MD, PhD, University of North Carolina at Chapel Hill

    Super@: 1:16

    Runs: 20

     

    “After one year, we found no significant differences in A1C or glycemic control between the three groups. Also there were no significant differences in health-related quality of life.”

     

     “The next steps are getting the message out and really helping patients understand as well as health care providers the message from this study…and helping patients feel comfortable recognizing that testing may not be necessary especially for those who are used to doing it once or multiple times a day.”

     

    (b-roll in middle of 2nd bite of patient)

     

    VO:

    STUDY RESULTS DO NOT APPLY TO INSULIN-TREATED PATIENTS.   

     

    APRIL REESE SAYS THE RESULTS ARE WORTH A CONVERSATION WITH HER DOCTOR ABOUT THE VALUE OF SELF-MONITORING.

     

    (B ROLL: Doctor and patient talking)

     

    AUDIO:

    SOT/FULL

    April Reese, Living with Type 2 Diabetes

    Super@: 1:44

    Runs:11

     

    “I will talk with my doctor about these results so that we can look at my treatment plan and make some decisions moving forward about how I want to be managed.”

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: Dr. talking to patient)

     

    TAG: THE STUDY WAS PERFORMED AT 15 PRIMARY CARE PRACTICES IN NORTH CAROLINA.

     

     

  • June 01, 2017

    Smartphone Video of Acute Onset of Uncontrolled Eye Movement

    Smartphone Video of Acute Onset of Uncontrolled Eye Movement

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

    JAMA Otolaryngology-Head & Neck Surgery

    Embed this video: Copy and paste the link below to embed the video on your website.

  • June 01, 2017

    After Treatment for Acute Onset of Uncontrolled Eye Movement

    After Treatment for Acute Onset of Uncontrolled Eye Movement

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

    JAMA Otolaryngology-Head & Neck Surgery

    Embed this video: Copy and paste the link below to embed the video on your website.

  • June 01, 2017

    Video Accompanies JAMA Facial Plastic Surgery Surgical Pearls Article

    Video Accompanies JAMA Facial Plastic Surgery Surgical Pearls Article

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

     

    JAMA Facial Plastic Surgery

    A video accompanies the Surgical Pears article, “The Columella Retraction Suture: A Powerful Suture Technique,” published by JAMA Facial Plastic Surgery.

    For more details and to view the video and get the embed code, please visit the For The Media website.

    (doi:10.1001/jamafacial.2017.0215)

    Editor’s Note:  Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

    #  #  #

    Embed this video: Copy and paste the link below to embed the video on your website.

  • May 16, 2017

    Corticosteroid Injections for Knee Osteoarthritis

    Corticosteroid Injections for Knee Osteoarthritis

    INTRO: Knee osteoarthritis affects millions of people in the United States and there are no known treatments that stop progression of the condition. A new study in JAMA investigates whether corticosteroid injections could slow the progression of cartilage loss and alleviate the pain of knee osteoarthritis. Laura Berger has more in this week’s JAMA report.

    AUDIO:

    VO:

    KNEE OSTEOARTHRITIS IS A LEADING CAUSE OF DISABILITY AND A DRIVER OF RISING MEDICAL COSTS BECAUSE THE PAINFUL CONDITION CAN OFTEN LEAD TO KNEE REPLACEMENT SURGERY.

    (B-ROLL: doctor checking patient’s knees)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 10

    Runs: 22

    “It’s expensive because of out of pocket costs for medical treatments, work loss, and also being the main reason for needing a joint replacement. Furthermore, there is currently no treatment accepted to benefit osteoarthritis in the long term and especially to reduce its rate of progression.”

    AUDIO:

    VO:

    1. TIMOTHY MCALINDON OF TUFTS MEDICAL CENTER IN BOSTON AND HIS COLLEAGUES STUDIED 140 ADULTS WITH KNEE OSTEOARTHRITIS IN A RANDOMIZED CLINICAL TRIAL.

    HALF OF THE PATIENTS RECEIVED A KNEE INJECTION OF THE CORTICOSTEROID TRIAMCINOLONE EVERY THREE MONTHS FOR TWO YEARS, WHILE THE OTHER HALF GOT SALT WATER INJECTIONS.

    THE RESEARCHERS MEASURED THE LEVEL OF KNEE PAIN AT EACH VISIT AND PERFORMED MRI SCANS ANNUALLY TO MEASURE CHANGES IN CARTILAGE AND OTHER STRUCTURES WITHIN THE JOINT.

    THE STUDY APPEARS IN JAMA, THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

    (B-ROLL: Dr. examining patient, knee exercises, steroid close up, knee exam, various MRI scans)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 1:04

    Runs: 39 seconds

    (broll comes in at 1:11—1:37 of doctor examining patient, MRI scans, and the steroid)

    “Both groups experienced some improvement in pain but there was no difference between the groups at any time point. Physical function remained about the same, and when we looked at the MRI scans, while there were no major differences between the groups, the precise measures of cartilage and volume showed more loss in the group that had been assigned to the corticosteroid. // The results of the studies do not support the use of long term repeated corticosteroid injections for the management of pain, or structural progression in osteoarthritis and in fact indicate that there may be more cartilage loss in people who receive steroids.”

    VO: DR. MCALINDON SAYS MORE WORK NEEDS TO BE DONE TO FIND A LONG-TERM SOLUTION FOR PEOPLE WITH KNEE OSTEOARTHRTIS.

    (B ROLL: Doctor and patient knee exam)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 1:49

    Runs:15

    “Osteoarthritis is a very common disorder for which there is currently no effective long-term treatment so we need to find interventions to reduce the incidence and progression of this disabling disorder.”

    VO:

    LAURA BERGER, THE JAMA REPORT

    (BROLL: Dr. talking to patient)

    THE STUDY WAS PERFORMED AT TUFTS MEDICAL CENTER FROM 2011 to 2015.

  • April 18, 2017

    Study Examines Effectiveness of Steroid Medication for Sore Throat

    Study Examines Effectiveness of Steroid Medication for Sore Throat

    Study Examines Effectiveness of Steroid Medication for Sore Throat”

    TRT: 1:47

    INTRO: SORE THROAT IS A COMMON SYMPTOM THAT SENDS PATIENTS TO THEIR DOCTORS, WHO OFTEN PRESCRIBE ANTIBIOTICS WHEN THEY WON’T HELP AND AREN’T NEEDED. FINDING ALTERNATIVE STRATEGIES TO RELIEVE SORE THROAT SYMPTOMS AND REDUCE ANTIBIOTIC USE IS IMPORTANT. A NEW STUDY IN JAMA INVESTIGATES WHETHER A CORTICOSTEROID PILL RESOLVES SORE THROAT SYMPTOMS IN ADULTS WHO DON’T REQUIRE ANTIBIOTICS. LAURA BERGER HAS MORE IN THIS WEEK’S JAMA REPORT.

    AUDIO:

    VO:

     PATIENTS IN THE U.S. MADE 92 MILLION VISITS TO DOCTORS FOR SORE THROATS BETWEEN 1997 AND 2010. MANY OF THOSE PATIENTS RECEIVED UNNECESSARY ANTIBIOTICS.

    (B-ROLL: doctor checking patient’s throat)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 11

    Runs: 14

    “We know the more antibiotics that we take, the more likely we are to develop infections which are resistant to antibiotics in the future. So it’s important to try and find alternative treatments…we wanted to know if steroids could be an alternative treatment for sore throat.”

    AUDIO:

    VO:

    1. GAIL HAYWARD OF THE UNIVERSITY OF OXFORD AND HER COLLEAGUES STUDIED ALMOST 600 ADULTS WITH SORE THROATS WHO DIDN’T REQUIRE IMMEDIATE ANTIBIOTICS FROM CLINICS IN ENGLAND AS PART OF A RANDOMIZED TRIAL. HALF THE PATIENTS TOOK A 10-MILLIGRAM DOSE OF THE CORTICOSTEROID DEXAMETHASONE WHILE THE OTHER HALF RECEIVED A PLACEBO.

    THE RESEARCHERS THEN MEASURED WHETHER SORE THROAT SYMPTOMS WERE COMPLETELY RESOLVED AFTER ONE OR TWO DAYS.

    THE STUDY APPEARS IN JAMA, THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

    (B-ROLL: Dr. Hayward walking down hallway, working on computer, patient getting throat exam, shot of dexamethasone, patient exam)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 53

    Runs: 17

    “After 24 hours, we didn’t see any difference in the proportion of patients who felt better between those taking the steroid and those taking the placebo. However, at 48 hours we did see a difference, more patients in the group that took the steroid tablet felt completely better, than patients in the placebo group.”

    VO: ALTHOUGH MORE PATIENTS WHO TOOK THE STEROID FELT COMPLETELY BETTER AFTER 48 HOURS, DR. HAYWARD SAYS THERE ARE MANY DOWNSIDES TO TAKING STEROIDS, INCLUDING DIFFICULTY SLEEPING, ACID REFLUX, AND INCREASED APPETITE.

    (B ROLL: Doctor checking patient’s ears, talking to patient, shot of drug)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 1:23

    Runs: 23

    “We think that although steroids are probably not ideal to be used in primary care for all patients presenting with sore throat, what our study couldn’t really do is look at those patients with very severe sore throat. We think that its possible that in very severe sore throat steroids might help patients be able to swallow fluids and medication, and avoid needing to go to hospital which could be very beneficial, but this research has not yet been done.​”

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: Doctor using tongue depressor on patient)

    TAG: THE STUDY STARTED IN 2013 AND ENDED IN 2015.

  • March 28, 2017

    Screening for Celiac Disease: USPSTF Recommendation Statement

    Screening for Celiac Disease: USPSTF Recommendation Statement

    Celiac disease is intolerance to gluten, a protein complex found in wheat and some other grains.  When people with celiac disease eat foods with gluten their immune response damages the lining of the small intestine, causing gastrointestinal and other symptoms.

    The selection of gluten-free foods in the grocery store is proof enough that many people worry they might have celiac disease, but should doctors be screening people for it?

    Remember, screening means looking for disease in people without symptoms or signs of it;

    Screening for celiac disease typically involves drawing blood for serum antibody levels and following up with an intestinal biopsy.

    The United States Preventive Services Task Force, an independent volunteer panel of national experts in prevention and evidence-based medicine, has now reviewed the literature and concludes that we don’t have enough information to know.

    Some groups still recommend screening higher risk patients for celiac disease, but the Task Force says there are simply no good studies demonstrating the accuracy of testing in asymptomatic populations, or the benefits and harms of early detection and treatment of screen-detected disease.

    So if your patients’ main symptom is anxiety about gluten sensitivity or celiac disease, you’re probably OK holding off on testing, unless other symptoms raise suspicions for the disorder. And if you do screen, patients should understand that the balance of benefit and harm is uncertain.

    Thanks for listening, hope to see you soon and don’t forget to click the link in the description to read the entire recommendation statement.

  • February 21, 2017

    The Effects of Testosterone Gel on Health Outcomes

    The Effects of Testosterone Gel on Health Outcomes

    INTRO: Can testosterone gel improve memory, correct anemia, increase bone density or prevent the growth of coronary artery plaque in older men with low testosterone levels? Four new studies in JAMA and JAMA Internal Medicine found improvement in some of these measures.  Laura Berger has more in this week’s JAMA Report.

     

    AUDIO:

    VO:

     

    LOW TESTOSTERONE LEVELS ARE COMMON IN OLDER MEN. FOUR NEW STUDIES IN JAMA AND JAMA INTERNAL MEDICINE LOOKED AT WHETHER USING A TESTOSTERONE GEL COULD AFFECT CERTAIN HEALTH OUTCOMES.

     

    (B-ROLL:

    Men working out on a track, and stretching, Close-up of testosterone gel, walking on track)

     

     

    AUDIO:

    SOT/FULL

    Peter Snyder, MD, Professor of Medicine, University of Pennsylvania

    Super@: 12

    Runs: 19

     

    “We selected men over 65 who had low testosterone levels. We treated them with either testosterone or placebo for one year.  We studied their blood counts, their bone density, the amount of plaque in their coronary arteries, and their memory.”

     

     

     

    AUDIO:

    VO:

     

    THE WORK BY DR. PETER SNYDER OF THE UNIVERSITY OF PENNSYLVANIA AND HIS CO-AUTHORS WAS PART OF A GROUP OF COORDINATED TRIALS ON THE EFFECTS OF TESTOSTERONE GEL IN OLDER MEN WITH LOW TESTOSTERONE LEVELS.

     

    RESEARCHERS FOUND THE TESTOSTERONE GEL CORRECTED ANEMIA AND INCREASED BONE DENSITY MORE THAN PLACEBO, BUT IT DID NOT IMPROVE MEMORY AND IT INCREASED THE AMOUNT OF CORONARY ARTERY PLAQUE.

     

    1. SNYDER SAYS THAT THE INCREASE IN THE AMOUNT OF CORONARY ARTERY PLAQUE COULD BE AN EARLY SIGN OF INCREASED RISK OF HEART PROBLEMS. AND THE STUDIES DID NOT LOOK AT PROSTATE CANCER, WHICH CAN GROW IN RESPONSE TO TESTOSTERONE.

     

    (B-ROLL: Dr. Snyder walking down the hall, on the phone, working on computer, Testosterone gel bottle, doctor with gel and patient, men stretching at gym, man on computer, picture of artery, bottle of testosterone gel)

     

    AUDIO

    SOT/FULL

    Peter Snyder, MD, Professor of Medicine, University of Pennsylvania

    Super@ 1:04

    Runs: 17

     

    “The next step is to conduct a much larger and longer trial say of 5,000 men for 5 years to determine if testosterone increases the risk of heart attack or increases the risk of prostate cancer. Or if it reduces the risk of bone fracture.”

     

     

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: men walking on a track)

     

    TAG: THE TESTOSTERONE TRIALS WERE CONDUCTED FROM 2010 TO 2014.

  • January 30, 2017

    Mentally Stimulating Activities in Late Life and Risk of Mild Cognitive Impairment

    Mentally Stimulating Activities in Late Life and Risk of Mild Cognitive Impairment

    INTRO: Can brain-stimulating activities help older adults lower their risk of developing mild cognitive impairment? A new study in JAMA Neurology suggests certain activities may be associated with less risk. Laura Berger has more in this week’s JAMA Report.

     

    AUDIO:

    VO:

    MILD COGNITIVE IMPAIRMENT OR MCI IS THE INTERMEDIATE STAGE BETWEEN NORMAL AGING AND DEMENTIA.

     

     

    (B-roll: woman working at a computer)

     

     

    SOT/FULL

    Yonas Geda, MD, MSc, Professor of Neurology and Psychiatry, Mayo Clinic

    Super@:8

    Runs:16

     

    “The frequency of MCI, depends on age. If you take a person 70 year and older, for example in our study, we have observed that the frequency or prevalence of MCI is about 15%.”

     

    AUDIO:

    VO:

     

    1. YONAS GEDA (GAY-da) OF THE MAYO CLINIC IN SCOTTSDALE, ARIZONA AND CO-AUTHORS STUDIED ALMOST 2 THOUSAND COGNITIVELY NORMAL ADULTS 70 AND OLDER TO SEE IF ENGAGING IN MENTALLY STIMULATING ACTVITIES WAS ASSOCIATED WITH DECREASED RISK FOR DEVELOPING MCI.

     

    THE OLDER ADULTS WERE FROM A MAYO CLINIC STUDY OF AGING IN MINNESOTA. THEY COMPLETED QUESTIONNAIRES ABOUT THEIR ACTIVITIES AND UNDERWENT ASSESSMENTS, INCLUDING FOR MEMORY. 

     

    RESEARCHERS FOUND PLAYING GAMES, CRAFTING, USING A COMPUTER AND SOCIAL ACTIVITIES WERE ASSOCIATED WITH DECREASED RISK OF MCI.

     

     

     

    (B-ROLL:

    Dr. walking with a woman, looking at data, man on I-pad, woman doing a puzzle, man on I-pad, woman with doctor)

     

    AUDIO:

    Yonas Geda, MD, MSc, Professor of Neurology and Psychiatry, Mayo Clinic

    Super@:49

    Runs:15

    SOT/FULL

     

    “This study is very important because dementia, MCI, these conditions are really common as we get older. We need to find out non-pharmacological approach to decrease the risk of MCI or dementia.”

     

    LAURA BERGER, THE JAMA REPORT

    (BROLL: woman doing a puzzle)

     

         TAG:THE STUDY LOOKED AT DATA FROM APRIL 2006 TO JUNE 2016.

     

  • June 13, 2017

    Video of drone delivering an AED

  • June 10, 2017

    Glucose Self-Monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes

    Glucose Self-Monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes

    TRT:

     

    INTRO: Many people with type 2 diabetes not treated with insulin self-monitor their blood sugar levels. But the value of this practice has been debated. So how effective is self-monitoring for these patients when it comes to glycemic control and health-related quality of life? A new study in JAMA Internal Medicine investigates. Laura Berger has more in this week’s JAMA report.

     

    AUDIO:

    VO:

     

    MANY PATIENTS WITH TYPE 2 DIABETES NOT TREATED WITH INSULIN SELF MONITOR THEIR BLOOD SUGAR LEVELS AT HOME … PATIENTS LIKE APRIL REESE.

     

    (B-ROLL: Doctor and patient April talking and looking at paper of levels)

     

    AUDIO:

    SOT/FULL

    April Reese, Living with Type 2 Diabetes

    Super@: 7

    Runs: 9

     

    “A couple of times a week I am testing to make sure that I’m in the right range or if I feel like something’s wrong I test.”

     

    AUDIO:

    VO:

    BUT HOW EFFECTIVE IS SELF- MONITORING FOR PATIENTS LIKE APRIL? DR. KATRINA DONAHUE AND DR. LAURA YOUNG OF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL AND THEIR COLLEAGUES STUDIED 450 ADULTS WHO HAD NON-INSULIN-TREATED TYPE 2 DIABETES.

     

    RESEARCHERS WANTED TO KNOW IF SELF-MONITORING BLOOD GLUCOSE LEVELS AFFECTED DIABETES CONTROL BY LOOKING AT PATIENTS’ HEMOGLOBIN A1C LEVELS, A MEASURE OF LONGER-TERM SUGAR CONTROL, OR THEIR HEALTH-RELATED QUALITY OF LIFE.

    IN THE RANDOMIZED TRIAL, PATIENTS

    WERE DIVIDED INTO THREE GROUPS, ONE GROUP DID NOT DO SELF-MONITORING, THE SECOND GROUP DID ONCE DAILY SELF-MONITORING, AND THE THIRD GROUP MONITORED ONCE DAILY TOO BUT ALSO RECEIVED MESSAGES WITH ENCOURAGEMENT OR INSTRUCTION THROUGH THEIR METER.

     

    THE STUDY APPEARS IN JAMA INTERNAL MEDICINE.

     

    (B-ROLL: Dr. and April talking, Drs. Walking down the hall, Drs. at computer, April preparing to test her blood, looking at levels, checking foot, April testing blood, looking at monitor with Doctor)

     

     

    AUDIO:

    SOT/FULL

    Katrina Donahue MD, MPH, University of North Carolina at Chapel Hill

    Super@: 1:02

    Runs: 13

     

    SOT/FULL

    Laura Young MD, PhD, University of North Carolina at Chapel Hill

    Super@: 1:16

    Runs: 20

     

    “After one year, we found no significant differences in A1C or glycemic control between the three groups. Also there were no significant differences in health-related quality of life.”

     

     “The next steps are getting the message out and really helping patients understand as well as health care providers the message from this study…and helping patients feel comfortable recognizing that testing may not be necessary especially for those who are used to doing it once or multiple times a day.”

     

    (b-roll in middle of 2nd bite of patient)

     

    VO:

    STUDY RESULTS DO NOT APPLY TO INSULIN-TREATED PATIENTS.   

     

    APRIL REESE SAYS THE RESULTS ARE WORTH A CONVERSATION WITH HER DOCTOR ABOUT THE VALUE OF SELF-MONITORING.

     

    (B ROLL: Doctor and patient talking)

     

    AUDIO:

    SOT/FULL

    April Reese, Living with Type 2 Diabetes

    Super@: 1:44

    Runs:11

     

    “I will talk with my doctor about these results so that we can look at my treatment plan and make some decisions moving forward about how I want to be managed.”

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: Dr. talking to patient)

     

    TAG: THE STUDY WAS PERFORMED AT 15 PRIMARY CARE PRACTICES IN NORTH CAROLINA.

     

     

  • June 01, 2017

    Smartphone Video of Acute Onset of Uncontrolled Eye Movement

    Smartphone Video of Acute Onset of Uncontrolled Eye Movement

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

    JAMA Otolaryngology-Head & Neck Surgery

    Embed this video: Copy and paste the link below to embed the video on your website.

  • June 01, 2017

    After Treatment for Acute Onset of Uncontrolled Eye Movement

    After Treatment for Acute Onset of Uncontrolled Eye Movement

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

    JAMA Otolaryngology-Head & Neck Surgery

    Embed this video: Copy and paste the link below to embed the video on your website.

  • June 01, 2017

    Video Accompanies JAMA Facial Plastic Surgery Surgical Pearls Article

    Video Accompanies JAMA Facial Plastic Surgery Surgical Pearls Article

    EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 1, 2017

     

    JAMA Facial Plastic Surgery

    A video accompanies the Surgical Pears article, “The Columella Retraction Suture: A Powerful Suture Technique,” published by JAMA Facial Plastic Surgery.

    For more details and to view the video and get the embed code, please visit the For The Media website.

    (doi:10.1001/jamafacial.2017.0215)

    Editor’s Note:  Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

    #  #  #

    Embed this video: Copy and paste the link below to embed the video on your website.

  • May 16, 2017

    Corticosteroid Injections for Knee Osteoarthritis

    Corticosteroid Injections for Knee Osteoarthritis

    INTRO: Knee osteoarthritis affects millions of people in the United States and there are no known treatments that stop progression of the condition. A new study in JAMA investigates whether corticosteroid injections could slow the progression of cartilage loss and alleviate the pain of knee osteoarthritis. Laura Berger has more in this week’s JAMA report.

    AUDIO:

    VO:

    KNEE OSTEOARTHRITIS IS A LEADING CAUSE OF DISABILITY AND A DRIVER OF RISING MEDICAL COSTS BECAUSE THE PAINFUL CONDITION CAN OFTEN LEAD TO KNEE REPLACEMENT SURGERY.

    (B-ROLL: doctor checking patient’s knees)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 10

    Runs: 22

    “It’s expensive because of out of pocket costs for medical treatments, work loss, and also being the main reason for needing a joint replacement. Furthermore, there is currently no treatment accepted to benefit osteoarthritis in the long term and especially to reduce its rate of progression.”

    AUDIO:

    VO:

    1. TIMOTHY MCALINDON OF TUFTS MEDICAL CENTER IN BOSTON AND HIS COLLEAGUES STUDIED 140 ADULTS WITH KNEE OSTEOARTHRITIS IN A RANDOMIZED CLINICAL TRIAL.

    HALF OF THE PATIENTS RECEIVED A KNEE INJECTION OF THE CORTICOSTEROID TRIAMCINOLONE EVERY THREE MONTHS FOR TWO YEARS, WHILE THE OTHER HALF GOT SALT WATER INJECTIONS.

    THE RESEARCHERS MEASURED THE LEVEL OF KNEE PAIN AT EACH VISIT AND PERFORMED MRI SCANS ANNUALLY TO MEASURE CHANGES IN CARTILAGE AND OTHER STRUCTURES WITHIN THE JOINT.

    THE STUDY APPEARS IN JAMA, THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

    (B-ROLL: Dr. examining patient, knee exercises, steroid close up, knee exam, various MRI scans)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 1:04

    Runs: 39 seconds

    (broll comes in at 1:11—1:37 of doctor examining patient, MRI scans, and the steroid)

    “Both groups experienced some improvement in pain but there was no difference between the groups at any time point. Physical function remained about the same, and when we looked at the MRI scans, while there were no major differences between the groups, the precise measures of cartilage and volume showed more loss in the group that had been assigned to the corticosteroid. // The results of the studies do not support the use of long term repeated corticosteroid injections for the management of pain, or structural progression in osteoarthritis and in fact indicate that there may be more cartilage loss in people who receive steroids.”

    VO: DR. MCALINDON SAYS MORE WORK NEEDS TO BE DONE TO FIND A LONG-TERM SOLUTION FOR PEOPLE WITH KNEE OSTEOARTHRTIS.

    (B ROLL: Doctor and patient knee exam)

    AUDIO:

    SOT/FULL

    Timothy McAlindon, DM, MPH, Tufts Medical Center

    Super@: 1:49

    Runs:15

    “Osteoarthritis is a very common disorder for which there is currently no effective long-term treatment so we need to find interventions to reduce the incidence and progression of this disabling disorder.”

    VO:

    LAURA BERGER, THE JAMA REPORT

    (BROLL: Dr. talking to patient)

    THE STUDY WAS PERFORMED AT TUFTS MEDICAL CENTER FROM 2011 to 2015.

  • April 18, 2017

    Study Examines Effectiveness of Steroid Medication for Sore Throat

    Study Examines Effectiveness of Steroid Medication for Sore Throat

    Study Examines Effectiveness of Steroid Medication for Sore Throat”

    TRT: 1:47

    INTRO: SORE THROAT IS A COMMON SYMPTOM THAT SENDS PATIENTS TO THEIR DOCTORS, WHO OFTEN PRESCRIBE ANTIBIOTICS WHEN THEY WON’T HELP AND AREN’T NEEDED. FINDING ALTERNATIVE STRATEGIES TO RELIEVE SORE THROAT SYMPTOMS AND REDUCE ANTIBIOTIC USE IS IMPORTANT. A NEW STUDY IN JAMA INVESTIGATES WHETHER A CORTICOSTEROID PILL RESOLVES SORE THROAT SYMPTOMS IN ADULTS WHO DON’T REQUIRE ANTIBIOTICS. LAURA BERGER HAS MORE IN THIS WEEK’S JAMA REPORT.

    AUDIO:

    VO:

     PATIENTS IN THE U.S. MADE 92 MILLION VISITS TO DOCTORS FOR SORE THROATS BETWEEN 1997 AND 2010. MANY OF THOSE PATIENTS RECEIVED UNNECESSARY ANTIBIOTICS.

    (B-ROLL: doctor checking patient’s throat)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 11

    Runs: 14

    “We know the more antibiotics that we take, the more likely we are to develop infections which are resistant to antibiotics in the future. So it’s important to try and find alternative treatments…we wanted to know if steroids could be an alternative treatment for sore throat.”

    AUDIO:

    VO:

    1. GAIL HAYWARD OF THE UNIVERSITY OF OXFORD AND HER COLLEAGUES STUDIED ALMOST 600 ADULTS WITH SORE THROATS WHO DIDN’T REQUIRE IMMEDIATE ANTIBIOTICS FROM CLINICS IN ENGLAND AS PART OF A RANDOMIZED TRIAL. HALF THE PATIENTS TOOK A 10-MILLIGRAM DOSE OF THE CORTICOSTEROID DEXAMETHASONE WHILE THE OTHER HALF RECEIVED A PLACEBO.

    THE RESEARCHERS THEN MEASURED WHETHER SORE THROAT SYMPTOMS WERE COMPLETELY RESOLVED AFTER ONE OR TWO DAYS.

    THE STUDY APPEARS IN JAMA, THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

    (B-ROLL: Dr. Hayward walking down hallway, working on computer, patient getting throat exam, shot of dexamethasone, patient exam)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 53

    Runs: 17

    “After 24 hours, we didn’t see any difference in the proportion of patients who felt better between those taking the steroid and those taking the placebo. However, at 48 hours we did see a difference, more patients in the group that took the steroid tablet felt completely better, than patients in the placebo group.”

    VO: ALTHOUGH MORE PATIENTS WHO TOOK THE STEROID FELT COMPLETELY BETTER AFTER 48 HOURS, DR. HAYWARD SAYS THERE ARE MANY DOWNSIDES TO TAKING STEROIDS, INCLUDING DIFFICULTY SLEEPING, ACID REFLUX, AND INCREASED APPETITE.

    (B ROLL: Doctor checking patient’s ears, talking to patient, shot of drug)

    AUDIO:

    SOT/FULL

    Gail Hayward, DPhil, MRCG, University of Oxford

    Super@: 1:23

    Runs: 23

    “We think that although steroids are probably not ideal to be used in primary care for all patients presenting with sore throat, what our study couldn’t really do is look at those patients with very severe sore throat. We think that its possible that in very severe sore throat steroids might help patients be able to swallow fluids and medication, and avoid needing to go to hospital which could be very beneficial, but this research has not yet been done.​”

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: Doctor using tongue depressor on patient)

    TAG: THE STUDY STARTED IN 2013 AND ENDED IN 2015.

  • March 28, 2017

    Screening for Celiac Disease: USPSTF Recommendation Statement

    Screening for Celiac Disease: USPSTF Recommendation Statement

    Celiac disease is intolerance to gluten, a protein complex found in wheat and some other grains.  When people with celiac disease eat foods with gluten their immune response damages the lining of the small intestine, causing gastrointestinal and other symptoms.

    The selection of gluten-free foods in the grocery store is proof enough that many people worry they might have celiac disease, but should doctors be screening people for it?

    Remember, screening means looking for disease in people without symptoms or signs of it;

    Screening for celiac disease typically involves drawing blood for serum antibody levels and following up with an intestinal biopsy.

    The United States Preventive Services Task Force, an independent volunteer panel of national experts in prevention and evidence-based medicine, has now reviewed the literature and concludes that we don’t have enough information to know.

    Some groups still recommend screening higher risk patients for celiac disease, but the Task Force says there are simply no good studies demonstrating the accuracy of testing in asymptomatic populations, or the benefits and harms of early detection and treatment of screen-detected disease.

    So if your patients’ main symptom is anxiety about gluten sensitivity or celiac disease, you’re probably OK holding off on testing, unless other symptoms raise suspicions for the disorder. And if you do screen, patients should understand that the balance of benefit and harm is uncertain.

    Thanks for listening, hope to see you soon and don’t forget to click the link in the description to read the entire recommendation statement.

  • February 21, 2017

    The Effects of Testosterone Gel on Health Outcomes

    The Effects of Testosterone Gel on Health Outcomes

    INTRO: Can testosterone gel improve memory, correct anemia, increase bone density or prevent the growth of coronary artery plaque in older men with low testosterone levels? Four new studies in JAMA and JAMA Internal Medicine found improvement in some of these measures.  Laura Berger has more in this week’s JAMA Report.

     

    AUDIO:

    VO:

     

    LOW TESTOSTERONE LEVELS ARE COMMON IN OLDER MEN. FOUR NEW STUDIES IN JAMA AND JAMA INTERNAL MEDICINE LOOKED AT WHETHER USING A TESTOSTERONE GEL COULD AFFECT CERTAIN HEALTH OUTCOMES.

     

    (B-ROLL:

    Men working out on a track, and stretching, Close-up of testosterone gel, walking on track)

     

     

    AUDIO:

    SOT/FULL

    Peter Snyder, MD, Professor of Medicine, University of Pennsylvania

    Super@: 12

    Runs: 19

     

    “We selected men over 65 who had low testosterone levels. We treated them with either testosterone or placebo for one year.  We studied their blood counts, their bone density, the amount of plaque in their coronary arteries, and their memory.”

     

     

     

    AUDIO:

    VO:

     

    THE WORK BY DR. PETER SNYDER OF THE UNIVERSITY OF PENNSYLVANIA AND HIS CO-AUTHORS WAS PART OF A GROUP OF COORDINATED TRIALS ON THE EFFECTS OF TESTOSTERONE GEL IN OLDER MEN WITH LOW TESTOSTERONE LEVELS.

     

    RESEARCHERS FOUND THE TESTOSTERONE GEL CORRECTED ANEMIA AND INCREASED BONE DENSITY MORE THAN PLACEBO, BUT IT DID NOT IMPROVE MEMORY AND IT INCREASED THE AMOUNT OF CORONARY ARTERY PLAQUE.

     

    1. SNYDER SAYS THAT THE INCREASE IN THE AMOUNT OF CORONARY ARTERY PLAQUE COULD BE AN EARLY SIGN OF INCREASED RISK OF HEART PROBLEMS. AND THE STUDIES DID NOT LOOK AT PROSTATE CANCER, WHICH CAN GROW IN RESPONSE TO TESTOSTERONE.

     

    (B-ROLL: Dr. Snyder walking down the hall, on the phone, working on computer, Testosterone gel bottle, doctor with gel and patient, men stretching at gym, man on computer, picture of artery, bottle of testosterone gel)

     

    AUDIO

    SOT/FULL

    Peter Snyder, MD, Professor of Medicine, University of Pennsylvania

    Super@ 1:04

    Runs: 17

     

    “The next step is to conduct a much larger and longer trial say of 5,000 men for 5 years to determine if testosterone increases the risk of heart attack or increases the risk of prostate cancer. Or if it reduces the risk of bone fracture.”

     

     

    VO:

    LAURA BERGER, THE JAMA REPORT

     

    (BROLL: men walking on a track)

     

    TAG: THE TESTOSTERONE TRIALS WERE CONDUCTED FROM 2010 TO 2014.

  • January 30, 2017

    Mentally Stimulating Activities in Late Life and Risk of Mild Cognitive Impairment

    Mentally Stimulating Activities in Late Life and Risk of Mild Cognitive Impairment

    INTRO: Can brain-stimulating activities help older adults lower their risk of developing mild cognitive impairment? A new study in JAMA Neurology suggests certain activities may be associated with less risk. Laura Berger has more in this week’s JAMA Report.

     

    AUDIO:

    VO:

    MILD COGNITIVE IMPAIRMENT OR MCI IS THE INTERMEDIATE STAGE BETWEEN NORMAL AGING AND DEMENTIA.

     

     

    (B-roll: woman working at a computer)

     

     

    SOT/FULL

    Yonas Geda, MD, MSc, Professor of Neurology and Psychiatry, Mayo Clinic

    Super@:8

    Runs:16

     

    “The frequency of MCI, depends on age. If you take a person 70 year and older, for example in our study, we have observed that the frequency or prevalence of MCI is about 15%.”

     

    AUDIO:

    VO:

     

    1. YONAS GEDA (GAY-da) OF THE MAYO CLINIC IN SCOTTSDALE, ARIZONA AND CO-AUTHORS STUDIED ALMOST 2 THOUSAND COGNITIVELY NORMAL ADULTS 70 AND OLDER TO SEE IF ENGAGING IN MENTALLY STIMULATING ACTVITIES WAS ASSOCIATED WITH DECREASED RISK FOR DEVELOPING MCI.

     

    THE OLDER ADULTS WERE FROM A MAYO CLINIC STUDY OF AGING IN MINNESOTA. THEY COMPLETED QUESTIONNAIRES ABOUT THEIR ACTIVITIES AND UNDERWENT ASSESSMENTS, INCLUDING FOR MEMORY. 

     

    RESEARCHERS FOUND PLAYING GAMES, CRAFTING, USING A COMPUTER AND SOCIAL ACTIVITIES WERE ASSOCIATED WITH DECREASED RISK OF MCI.

     

     

     

    (B-ROLL:

    Dr. walking with a woman, looking at data, man on I-pad, woman doing a puzzle, man on I-pad, woman with doctor)

     

    AUDIO:

    Yonas Geda, MD, MSc, Professor of Neurology and Psychiatry, Mayo Clinic

    Super@:49

    Runs:15

    SOT/FULL

     

    “This study is very important because dementia, MCI, these conditions are really common as we get older. We need to find out non-pharmacological approach to decrease the risk of MCI or dementia.”

     

    LAURA BERGER, THE JAMA REPORT

    (BROLL: woman doing a puzzle)

     

         TAG:THE STUDY LOOKED AT DATA FROM APRIL 2006 TO JUNE 2016.